Percorrendo por Autor CASTELLANO, DANIEL
Mostrando regs. 1 a 4 de 4
Data de publicação | Título | Autor(es) |
2020 | Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial | VAN DER HEIJDEN, MICHIEL S; GALSKY, MATTHEW D; PETRYLAK, DANIEL P, et al |
2020 | Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma | LORIOT, YOHANN; STERNBERG, CORA N.; CASTELLANO, DANIEL, et al |
2018 | The Clinical Activity of PD-1/PD-L1 inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma | MCKAY, RANA R.; BOSSÉ, DOMINICK; XIE, WANLING, et al |
2018 | The Clinical Activity of PD-1/PD-L1 inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma | MCKAY, RANA R.; BOSSÉ, DOMINICK; XIE, WANLING, et al |